Dr. Randy Nelson, Arizona State University (IMAGE)

Arizona State University

Dr. Randy Nelson, Arizona State University

Caption

Randy Nelson, director of the Molecular Biosignatures Analysis Unit at ASUs Biodesign Institute, will lead a $5 million NIH initiative to advance diabetes care and treatment.

Credit

Biodesign Institute, Arizona State University

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.